(Q34432976)

2 August 2017

1 reference

title

Hypoglycemia-associated autonomic failure in diabetes. (English)

1 reference

2 August 2017

1 reference

Cryer PE

1

1 reference

2 August 2017

1 December 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

2 August 2017

1 reference

2 August 2017

281

1 reference

2 August 2017

6

1 reference

2 August 2017

E1115-21

1 reference

IRS proteins and beta-cell function

2 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Adaptation in brain glucose uptake following recurrent hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Defective glucose-regulated insulin gene expression associated with PDX-1 deficiency in the Psammomys obesus model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Reevaluation of the major histocompatibility complex genes of the NOD-progenitor CTS/Shi strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.6.E1115

10.1152/AJPENDO.2001.281.6.E1115

21 January 2018

Identifiers

DOI

0 references

PubMed ID

11701423

1 reference

PubMed ID

11701423